BT
Better Therapeutics, Inc.
BTTX · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.45K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 273.72%
Asset turnover 0.00x
ROA 173.30%
Debt
64 /100
Moderate Current ratio 1.37x
Net debt/EBITDA 0.02x
Int. coverage -25.66x
Stability
1 /100
Unstable Beta 0.18x
Profitable years 0
EPS volatility 167.43%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o BTTX
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Craig R. Jalbert
Employees
54
Headquarters
San Francisco
Nadchodzące wydarzenia
12 LIS
Earnings
Upcoming earnings report